Medication info
Acyvir Tablet (Acyclovir)

Acyvir Tablet (Acyclovir)

Prescription medicationTabletIntravenous injection
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
K.S. Pharmaceutical Co., Ltd.
Appearance
Light blue round tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202003245 · Approved 2020.05.01 · Insurance code 059000810

Summary

Main use
Treatment and prevention of herpes simplex, treatment of herpes zoster, and treatment of chickenpox in children aged 2 years and older
Who receives it
Adults · Children
Adult administration
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended for severe initial infections. 2) In patients with severe immunodeficiency (such as after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection. For recurrent infections, treatment should preferably begin at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may subsequently be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, treatment should be periodically discontinued every 6 ~ 12 months in patients receiving long-term treatment. 3. Prevention of herpes simplex infections in patients with reduced immune function 1) Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (such as after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this medicine per dose 5 times daily at approximately 4-hour intervals, except during sleep, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunodeficiency or gastrointestinal malabsorption. 3) It is best to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more susceptible to neuropsychiatric adverse reactions; use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated following intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this medicine every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose twice daily, at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per dose 3 times daily, at approximately 8-hour intervals.
Child administration
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in patients with reduced immune function Age 2 years or older: Same as the adult dose. Younger than 2 years: Administer 1/2 of the adult dose. Reliable data are not yet available on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children aged 2 years or older: Administer 20 mg of this medicine per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours of rash onset.

Ingredients

Manufacturer
K.S. Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of herpes simplex, treatment of herpes zoster, and treatment of chickenpox in children aged 2 years and older

  • Primary genital herpes
  • recurrent genital herpes
  • herpes simplex virus infections of the skin and mucous membranes
  • shingles virus infections
  • acute pain
  • chickenpox
View approved original text

This medication is used to treat and prevent infections of the herpes simplex virus affecting skin and mucosal tissues, including primary and recurrent genital herpes. It is also effective in treating infections of the shingles virus, particularly for the relief of acute pain. However, its effect on postherpetic neuralgia has not yet been proven. It is also used to treat chickenpox in children over 2 years old. It is effectively used for various viral infections.

How it is given

Adult administration

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended for severe initial infections. 2) In patients with severe immunodeficiency (such as after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection. For recurrent infections, treatment should preferably begin at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may subsequently be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, treatment should be periodically discontinued every 6 ~ 12 months in patients receiving long-term treatment. 3. Prevention of herpes simplex infections in patients with reduced immune function 1) Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (such as after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this medicine per dose 5 times daily at approximately 4-hour intervals, except during sleep, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunodeficiency or gastrointestinal malabsorption. 3) It is best to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more susceptible to neuropsychiatric adverse reactions; use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated following intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this medicine every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose twice daily, at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per dose 3 times daily, at approximately 8-hour intervals.

Child administration

○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in patients with reduced immune function Age 2 years or older: Same as the adult dose. Younger than 2 years: Administer 1/2 of the adult dose. Reliable data are not yet available on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children aged 2 years or older: Administer 20 mg of this medicine per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours of rash onset.

Precautions

This medicine should not be used in patients who have had allergic reactions to this medication, its ingredients, or valacyclovir. It contains lactose, so patients with lactose intolerance or specific genetic metabolic disorders should not take it. Patients with impaired kidney function should be cautious as neurological side effects may manifest easily when using this medicine. Patients with poor liver function should also use it cautiously due to the risk of worsening liver function. Infants, children, and elderly individuals may experience side effects more readily, so administration should be done with care. This medication can rarely cause serious allergic reactions, such as anaphylactic shock; if symptoms like low blood pressure, difficulty breathing, or chest tightness occur, stop using it immediately and seek medical attention. Skin rash, fever, blisters, urticaria, etc. may occur, so discontinue use and consult your physician if these symptoms appear. Severe skin conditions, hair loss, mental confusion, seizures, drowsiness, and various neurological symptoms may occur, particularly in the elderly or those with decreased kidney function. Report any changes in urination, hematuria, or proteinuria to medical staff immediately as kidney function may decline. Be aware of hematologic symptoms like easy bruising or bleeding. Abnormal liver function symptoms, jaundice, or gastrointestinal symptoms like abdominal pain, nausea, or vomiting should also prompt a visit to the hospital. Adequate hydration is important while taking this medication, especially at high doses to prevent dehydration. For the treatment of shingles or chickenpox, it is effective to take the medication as soon as symptoms start. Awareness of potential consciousness disturbances arises during use; thus, it is advisable to avoid driving or operating dangerous machinery. Interactions may occur when taken with other medications, so if currently taking any drugs, make sure to inform your doctor or pharmacist. Women who are pregnant or may become pregnant should discuss the use of this medication with their physician as it may affect the fetus. In nursing mothers, this medication can be transferred to breast milk, therefore it is safer to cease breastfeeding while on this drug. In infants or children, it should be carefully administered at the minimum required dose only in necessary cases, especially in newborns or low birth weight infants as its safety has not been established. Elderly patients may have increased drug concentrations due to decreased kidney function, so dosage and administration intervals must be adjusted along with adequate hydration. In case of overdose, neurological symptoms and renal failure may occur, which necessitates immediate appropriate treatment at a hospital, and blood dialysis may be considered if necessary.

Side effects

  • Anaphylactic shock
  • anaphylactoid reaction
  • hypotension
  • difficulty breathing
  • chest tightness
  • photosensitivity reaction
  • fixed drug eruption
  • rash
  • fever
  • blisters
Show 122 more
  • urticaria-like erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • impaired concentration
  • aggressive behavior
  • depersonalization
  • restlessness
  • ataxia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • seizures
  • drowsiness
  • tremors
  • agitation
  • forgetfulness
  • insomnia
  • anxiety
  • soliloquy
  • paresthesia
  • ataxia
  • inability to walk
  • involuntary movement
  • nystagmus
  • dizziness
  • renal failure
  • crystalluria
  • elevated BUN
  • increased serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • bleeding
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • elevated AST
  • elevated ALT
  • increased LDH
  • elevated ALP
  • increased total bilirubin
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • loose stools
  • epigastric pain
  • gastric pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • fatigue
  • general malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • elevated blood pressure
  • lowered blood pressure
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disturbances
  • hair loss
  • sweating
  • hyponatremia
  • decreased serum protein
  • increased total cholesterol
  • elevated triglycerides
  • increased serum potassium
  • decreased serum albumin
  • restlessness
  • coma
  • seizures
  • drowsiness
  • confusion
  • hallucinations
  • agitation
  • seizure disorder
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a sealed container. Additionally, it should be kept in a cool, dry place below 25 degrees Celsius to maintain effectiveness.

Appearance and packaging

Appearance

Light blue round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.